George Stamatoyannopoulos
Corporate Officer/Principal chez University of Washington
Profil
George Stamatoyannopoulos is the founder of HemaQuest Pharmaceuticals, Inc. which was founded in 2007.
He held the title of Director from 2007 to 2013.
Dr. Stamatoyannopoulos is also the founder of Regulome Corp., Viracta Subsidiary, Inc. He is currently a Professor at the University of Washington.
Dr. Stamatoyannopoulos's former positions include being the President of the American Society of Hematology and the President of the American Society of Gene Therapy.
He received his graduate and doctorate degrees from the National & Kapodistrian University of Athens.
Postes actifs de George Stamatoyannopoulos
| Sociétés | Poste | Début |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Anciens postes connus de George Stamatoyannopoulos
| Sociétés | Poste | Fin |
|---|---|---|
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Founder | - |
Regulome Corp.
 Regulome Corp. Pharmaceuticals: MajorHealth Technology Regulome Corp. manufactures pharmaceutical products. It supplies medicines, vitamin supplements, and medical devices for applications in drug and diagnostic discovery development to the supermarket chains. The company was founded in 2001 by George Stamatoyannopoulos and is headquartered in Seattle, WA. | Founder | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | President | - |
| American Society of Gene Therapy | President | - |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Founder | - |
Formation de George Stamatoyannopoulos
| National & Kapodistrian University of Athens | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Regulome Corp.
Regulome Corp. Pharmaceuticals: MajorHealth Technology Regulome Corp. manufactures pharmaceutical products. It supplies medicines, vitamin supplements, and medical devices for applications in drug and diagnostic discovery development to the supermarket chains. The company was founded in 2001 by George Stamatoyannopoulos and is headquartered in Seattle, WA. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
| American Society of Gene Therapy | |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
